Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WeDerm is a Hong Kong-based health technology company specializing in the management of chronic skin conditions, particularly atopic dermatitis. The company provides a comprehensive digital health platform that combines personalized coaching, data-driven insights, and lifestyle interventions to help patients achieve long-term remission. WeDerm's approach integrates nutritional science, psychological support, and dermatological monitoring to address the root causes of skin inflammation. Their services are designed to empower patients through education and structured recovery programs, reducing the need for long-term steroid use. By leveraging data and a holistic care model, WeDerm aims to improve the quality of life for eczema sufferers through a science-backed, steroid-free methodology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wederm.